Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Clinical Research Ventures is a global venture capital firm established to support companies in funding their clinical trials for pharmaceuticals, diagnostics, and medical technologies. Founded with a clear mission, the firm does not engage in purely pre-clinical investments, ensuring that its focus remains on companies that are actively conducting clinical trials. The organization operates from offices in Boston and Europe, allowing it to invest in life sciences companies worldwide.
Currently, Clinical Research Ventures manages a portfolio of four notable companies, demonstrating its commitment to the life sciences sector. The firm has a structured approach to investment, partnering with clinical research organizations to facilitate rapid start-up, enrollment, and successful trial completion for its portfolio companies. This operational model enhances the development and commercialization of innovative medical technologies.
Clinical Research Ventures exclusively invests in companies conducting clinical trials within the life sciences sector. The firm targets investments across various stages, including Seed, Series A, Series B, Series C, and Growth Equity. Their investment strategy emphasizes funding for clinical trials in pharmaceuticals, diagnostics, and medical technologies, with a particular focus on companies entering Phase I or II clinical trials.
With an annual capacity of up to $50 million for trial costs, Clinical Research Ventures aims to enhance control and reduce dilution for biotech and medtech companies. The firm’s partnerships with clinical research organizations are designed to expedite trial processes, ensuring that portfolio companies can achieve successful outcomes efficiently.
Clinical Research Ventures has a focused portfolio that includes four notable companies:
Nuno Arantes-Oliveira: Based in Lisbon, Nuno brings extensive experience in life sciences investments and has a strong background in clinical research.
Jean Frederic Sauniere: Located in Côte d’Azur, Jean has a wealth of knowledge in venture capital and a focus on healthcare investments.
Stan Kugell: Operating from Boston, Stan has a proven track record in funding biotech companies and has led numerous successful investments in the sector.
To pitch Clinical Research Ventures, founders should reach out via email at contactus@cr-ventures.com. It is advisable to include a concise overview of the company, the clinical trial stage, and the specific funding needs in the pitch deck.
What are the investment criteria for Clinical Research Ventures?
Clinical Research Ventures invests exclusively in companies that are conducting clinical trials in the life sciences sector. They focus on companies entering Phase I or II clinical trials and do not invest in purely pre-clinical rounds.
How can I apply or pitch to Clinical Research Ventures?
Interested companies can apply for investment through the firm’s website. For inquiries, potential founders can reach out via email at contactus@cr-ventures.com.
What makes Clinical Research Ventures different from other investors?
The firm specializes in funding clinical trials and partners with clinical research organizations to facilitate rapid start-up and successful trial completion. This structured approach enhances the development of innovative medical technologies.
What is the geographic scope of Clinical Research Ventures?
Clinical Research Ventures operates globally, with offices in Boston and Europe, allowing them to invest in life sciences companies worldwide.
What is the typical check size for investments?
Clinical Research Ventures has an annual capacity of up to $50 million for trial costs, which can vary based on the specific needs of the portfolio companies.
What kind of post-investment involvement does Clinical Research Ventures have?
The firm actively partners with clinical research organizations to support its portfolio companies throughout the clinical trial process, ensuring they have the necessary resources for success.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.